AM-Pharma BV of the Netherlands has appointed Lars Boesgaard as chief financial officer to be based in the US, in preparation for the potential commercialisation of its candidate product for sepsis-associated acute kidney injury. Mr Boesgaard was most recently CFO at Columbia Care Inc, a cannabis company, and before that, CFO of Roka Bioscience Inc, a producer of molecular assays for the food safety industry. He holds a BSc in business administration from the Copenhagen Business School, and an MBA from Western University in Ontario, Canada.
AM-Pharma announced the appointment on 15 September 2021.
Copyright 2021 Evernow Publishing Ltd.